The justices sent the case back to a lower court to reassess the proper amount of damages.
The U.S. invests more than $32 billion each year in drug and biomedical research. Why doesn't the federal government then ensure reasonable prices for drugs developed with public funds -- an appropriate return on the public's investment?
Protect Inventors or Take Down Trolls? Patent Reform with Senator John Cornyn, CEO Innovestion, and Rackspace
Senator John Cornyn, Rackspace, and CEO-General Council Kevin Fiur share their insights on a few impending policies that will liberate the entrepreneur... or facilitate idea stealing.
Whatever course it chooses to take, Congress should stop those that want to undercut American innovation, particularly in the midst of a fragile economic recovery.
Congress should consider amending the patent law to appoint ethical representatives to the PTO. Its present staff, given their alternative professional backgrounds and competing professional responsibilities, cannot reasonably be expected to account for the relevant methodology and literature.
But what if you want to incentivize investment in bold new drugs instead of me-too drugs? What if you want to encourage research into new areas that tangibly improve people's health? Then maybe, like India, you would only grant patents when that higher standard is met.
One of the most complex and daunting challenges facing competition regulators is the evolving intersection of antitrust and intellectual property law.
Last September, our esteemed leaders in Washington passed a law reforming America's patent system called the Leahy-Smith America Invents Act. At the time, the promise from every politician in support of the Act was that it would create jobs.
While I would never -- and have never -- advocated for abolishing the patent system, because that would be throwing the baby out with the bath water, we do need to fix our patent system so that it rewards innovation, not manipulation.
it is critically important to the success of our patent system that it maintain high patent quality and ensures only deserving patents are issued. Unfortunately, the American patent system today is suffering from extremely low patent quality.